|
1
|
Fisher ER, Wang J, Bryant J, Fisher B,
Mamounas E and Wolmark N: Pathobiology of preoperative
chemotherapy: Findings from the National Surgical Adjuvant Breast
and Bowel (NSABP) protocol B-18. Cancer. 95:681–695. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kuerer HM, Sahin AA, Hunt KK, Newman LA,
Breslin TM, Ames FC, Ross MI, Buzdar AU, Hortobagyi GN and
Singletary SE: Incidence and impact of documented eradication of
breast cancer axillary lymph node metastases before surgery in
patients treated with neoadjuvant chemotherapy. Ann Surg.
230:72–78. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Klauber-DeMore N, Ollila DW, Moore DT,
Livasy C, Calvo BF, Kim HJ, Dees EC, Sartor CI, Sawyer LR, Graham M
II, et al: Size of residual lymph node metastasis after neoadjuvant
chemotherapy in locally advanced breast cancer patients is
prognostic. Ann Surg Oncol. 13:685–691. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kuerer HM, Newman LA, Smith TL, Ames FC,
Hunt KK, Dhingra K, Theriault RL, Singh G, Binkley SM, Sneige N, et
al: Clinical course of breast cancer patients with complete
pathologic primary tumor and axillary lymph node response to
doxorubicin-based neoadjuvant chemotherapy. J Clin Oncol.
17:460–469. 1999.PubMed/NCBI
|
|
5
|
Mamounas EP, Anderson SJ, Dignam JJ, Bear
HD, Julian TB, Geyer CE Jr, Taghian A, Wickerham DL and Wolmark N:
Predictors of locoregional recurrence after neoadjuvant
chemotherapy: Results from combined analysis of National Surgical
Adjuvant Breast and Bowel Project B-18 and B-27. J Clin Oncol.
30:3960–3966. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huang EH, Strom EA, Perkins GH, Oh JL,
Chen AM, Meric-Bernstam F, Hunt KK, Sahin AA, Hortobagyi GN and
Buchholz TA: Comparison of risk of local-regional recurrence after
mastectomy or breast conservation therapy for patients treated with
neoadjuvant chemotherapy and radiation stratified according to a
prognostic index score. Int J Radiat Oncol Biol Phys. 66:352–357.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Swain SM, Sorace RA, Bagley CS, Danforth
DN Jr, Bader J, Wesley MN, Steinberg SM and Lippman ME: Neoadjuvant
chemotherapy in the combined modality approach of locally advanced
nonmetastatic breast cancer. Cancer Res. 47:3889–3894.
1987.PubMed/NCBI
|
|
8
|
Mauri D, Pavlidis N and Ioannidis JP:
Neoadjuvant versus adjuvant systemic treatment in breast cancer: A
meta-analysis. J Natl Cancer Inst. 97:188–194. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fisher B, Brown A, Mamounas E, Wieand S,
Robidoux A, Margolese RG, Cruz AB Jr, Fisher ER, Wickerham DL,
Wolmark N, et al: Effect of preoperative chemotherapy on
local-regional disease in women with operable breast cancer:
Findings from National Surgical Adjuvant Breast and Bowel Project
B-18. J Clin Oncol. 15:2483–2493. 1997.PubMed/NCBI
|
|
10
|
Julian TB, Patel N, Dusi D, Olson P,
Nathan G, Jasnosz K, Isaacs G and Wolmark N: Sentinel lymph node
biopsy after neoadjuvant chemotherapy for breast cancer. Am J Surg.
182:407–410. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
van der Hage JA, van de Velde CJ, Julien
JP, Tubiana-Hulin M, Vandervelden C and Duchateau L: Preoperative
chemotherapy in primary operable breast cancer: Results from the
European Organization for Research and Treatment of Cancer trial
10902. J Clin Oncol. 19:4224–4237. 2001.PubMed/NCBI
|
|
12
|
Mieog JS, van der Hage JA and van de Velde
CJ: Neoadjuvant chemotherapy for operable breast cancer. Br J Surg.
94:1189–1200. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bloom HJ and Richardson WW: Histological
grading and prognosis in breast cancer; a study of 1409 cases of
which 359 have been followed for 15 years. Br J Cancer. 11:359–377.
1957. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Goldhirsch A, Winer EP, Coates AS, Gelber
RD, Piccart-Gebhart M, Thürlimann B, Senn HJ, Albain KS, Andre F,
Bergh J, et al: Panel members: Personalizing the treatment of women
with early breast cancer: Highlights of the St Gallen International
Expert Consensus on the Primary Therapy of Early Breast Cancer
2013. Ann Oncol. 24:2206–2223. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Abramoff MD, Magalhães PJ and Ram SJ:
Image processing with ImageJ. Biophotonics Int. 11:36–42. 2004.
|
|
16
|
Ogston KN, Miller ID, Payne S, Hutcheon
AW, Sarkar TK, Smith I, Schofield A and Heys SD: A new histological
grading system to assess response of breast cancers to primary
chemotherapy: Prognostic significance and survival. Breast.
12:320–327. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rajan R, Poniecka A, Smith TL, Yang Y,
Frye D, Pusztai L, Fiterman DJ, Gal-Gombos E, Whitman G, Rouzier R,
et al: Change in tumor cellularity of breast carcinoma after
neoadjuvant chemotherapy as a variable in the pathologic assessment
of response. Cancer. 100:1365–1373. 2004. View Article : Google Scholar : PubMed/NCBI
|
